Infusion therapy is a lifeline for people living with autoimmune disorders and chronic conditions. It’s also frequently ...
Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality ...
Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics (Nasdaq: PTGX) (“Protagonist”) announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking ...
A new drug application (NDA) has been submitted to the FDA seeking approval of rusfertide, an investigational hepcidin ...
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety Signals These Data ...
The archaic practice of removing blood from the body to treat a wide range of illnesses lives on today as a standard treatment for certain blood disorders. The modern version of this approach, called ...
ORLANDO, Fla. — Rusfertide, a weekly self-injected peptide, maintained control of hematocrit levels and reductions in phlebotomy requirements through 52 weeks in patients with polycythemia vera (PV), ...
An international collaboration led by Cornell University researchers used a combination of psilocybin and the rabies virus to map how – and where – the psychedelic compound rewires the connections in ...
AUBURN, Ala.— Zach Bryan is set to embark on his biggest international tour yet: With Heaven On Tour, a US and European run of dates including a finale at Jordan-Hare Stadium on October 10. The tour ...
Singer-songwriter Sombr debuted on Saturday Night Live with two hits from I Barely Know Her, his debut album that he released in August. The New York City native, who just picked up a Grammy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback